These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 498149)

  • 1. Structure-activity relationships of the antitumor platinum coordination complexes.
    Connors TA; Cleare MJ; Harrap KR
    Cancer Treat Rep; 1979; 63(9-10):1499-502. PubMed ID: 498149
    [No Abstract]   [Full Text] [Related]  

  • 2. Preclinical antitumor evaluation of bis-acetato-ammine-dichloro-cyclohexylamine platinum(IV): an orally active platinum drug.
    Kelland LR; Abel G; McKeage MJ; Jones M; Goddard PM; Valenti M; Murrer BA; Harrap KR
    Cancer Res; 1993 Jun; 53(11):2581-6. PubMed ID: 8388318
    [TBL] [Abstract][Full Text] [Related]  

  • 3. cis-Amminedichloro(2-methylpyridine) platinum(II) (AMD473), a novel sterically hindered platinum complex: in vivo activity, toxicology, and pharmacokinetics in mice.
    Raynaud FI; Boxall FE; Goddard PM; Valenti M; Jones M; Murrer BA; Abrams M; Kelland LR
    Clin Cancer Res; 1997 Nov; 3(11):2063-74. PubMed ID: 9815598
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Antitumor activity of mixed cis-complexes of platinum(II) with ammonia and cycloalkylamines].
    Konovalova AL; Presnov MA; Chel'tsov PA; Kravchenko AN; Ivanov VB
    Dokl Akad Nauk SSSR; 1985; 281(1):200-3. PubMed ID: 4039648
    [No Abstract]   [Full Text] [Related]  

  • 5. [Antitumor effect of complex compounds of tetravalent platinum].
    Konovalova AL; Presnov MA; Zheligovskaia NN; Treshchalina EM
    Dokl Akad Nauk SSSR; 1977; 234(1):223-6. PubMed ID: 880861
    [No Abstract]   [Full Text] [Related]  

  • 6. Circumvention of platinum resistance: structure-activity relationship for homologous series of ammine/amine platinum(II) complexes in L1210 cell lines.
    Yoshida M; Khokhar AR; Siddik ZH
    Anticancer Drug Des; 1994 Oct; 9(5):425-34. PubMed ID: 7945726
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Liposoluble platinum(II) complexes with antitumor activity.
    Maeda M; Uchida NA; Sasaki T
    Jpn J Cancer Res; 1986 Jun; 77(6):523-5. PubMed ID: 3015851
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antileukemia (L1210) activity and toxicity of cis-dichlorodiammineplatinum(II) analogs.
    Prestayko AW; Bradner WT; Huftalen JB; Rose WC; Schurig JE; Cleare MJ; Hydes PC; Crooke ST
    Cancer Treat Rep; 1979; 63(9-10):1503-8. PubMed ID: 498150
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel trans platinum complexes: comparative in vitro and in vivo activity against platinum-sensitive and resistant murine tumours.
    Goddard PM; Orr RM; Valenti MR; Barnard CF; Murrer BA; Kelland LR; Harrap KR
    Anticancer Res; 1996; 16(1):33-8. PubMed ID: 8615631
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preparation and antitumor evaluation of water-soluble derivatives of dichloro(1,2-diaminocyclohexane)platinum(II).
    Schwartz P; Meischen SJ; Gale GR; Atkins LM; Smith AB; Walker EM
    Cancer Treat Rep; 1977 Nov; 61(8):1519-25. PubMed ID: 922755
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacological and preclinical toxicological studies of 1,2-diaminocyclohexane(isocitrato)platinum(II).
    Macquet JP; Cros S; Armand JP
    Cancer Res; 1984 Sep; 44(9):3736-43. PubMed ID: 6540142
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modulatory effect of axial and equatorial ligands on antitumor activities of trans-1R,2R-diaminocyclohexane platinum(IV) complexes.
    Siddik ZH; al-Baker S; Thai G; Khokhar AR
    Anticancer Drug Des; 1994 Apr; 9(2):139-51. PubMed ID: 8166929
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Platinum coordination complexes which circumvent cisplatin resistance.
    Harrap KR; Kelland LR; Jones M; Goddard PM; Orr RM; Morgan SE; Murrer BA; Abrams MJ; Giandomenico CM; Cobbleigh T
    Adv Enzyme Regul; 1991; 31():31-43. PubMed ID: 1877393
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antitumor activity of amidoximes (hydroxyurea analogs) in murine tumor systems.
    Flora KP; van't Riet B; Wampler GL
    Cancer Res; 1978 May; 38(5):1291-5. PubMed ID: 639062
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Toxicity and anti-tumor activity of hydrophobic diammine and diaminocyclohexane platinum complexes entrapped in multilamellar vesicles.
    Khokhar AR; Al-Baker S; Perez-Soler R
    Anticancer Drug Des; 1988 Dec; 3(3):177-84. PubMed ID: 3207465
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis, cytotoxicity and antitumor activity of platinum(II) complexes of cyclopentanecarboxylic acid hydrazide.
    Kushev D; Gorneva G; Taxirov S; Spassovska N; Grancharov K
    Biol Chem; 1999 Nov; 380(11):1287-94. PubMed ID: 10614821
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lack of cross-resistance between certain platinum coordination compounds in mouse leukemia.
    Burchenal JH; Kalaher K; O'Toole T; Chisholm J
    Cancer Res; 1977 Sep; 37(9):3455-7. PubMed ID: 884687
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The prospect for cisplatin analogs from the experimental standpoint].
    Tashiro T
    Gan To Kagaku Ryoho; 1989 Apr; 16(4 Pt 2-2):1358-65. PubMed ID: 2543305
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Experimental antitumor activity and toxicity of a new chemotherapeutic agent, BBM 928A.
    Rose WC; Schurig JE; Huftalen JB; Bradner WT
    Cancer Res; 1983 Apr; 43(4):1504-10. PubMed ID: 6831399
    [No Abstract]   [Full Text] [Related]  

  • 20. Antitumor effects of three platinum complexes, (-)-(R)-2-aminomethylpyrrolidine(1,1-cyclobutanedicarboxylato)-platinum (II) monohydrate (DWA2114R), cis-diammine-(1,1-cyclobutanedicarboxylato)platinum(II) (CBDCA) and cis-diamminedichloroplatinum(II) (CDDP), in mice.
    Endo K; Akamatsu K; Matsumoto T; Morikawa K; Koizumi M; Mitsui H; Koizumi K
    Anticancer Res; 1992; 12(1):49-58. PubMed ID: 1567181
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.